Comparing a smart pill bottle app to standard pharmacy refills
Part of Digestive system clinical trials.
This study tests whether a smartphone app and special pill bottle help people take their acid reflux medication more regularly over 90 days.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 21 years old.
- You need a confirmed diagnosis of GERD (chronic acid reflux) or erosive esophagitis (acid damage to the esophagus).
- You must be currently taking a daily proton pump inhibitor (like omeprazole or esomeprazole) for at least 30 days before joining.
- You must be willing to fill your medication only at TidalHealth Community Pharmacy during the 90-day study.
- You need a smartphone (iPhone or Android) that can run the study app.
- You must be able to participate in English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a smartphone app called GERDCare helps people with GERD take their medications as prescribed. It may be a good fit if you have typical GERD symptoms like heartburn or regurgitation and are comfortable using a smartphone app.
This study tests a smartphone app that helps people with GERD (acid reflux) remember to take their medication. If you have heartburn or regurgitation and use a smartphone, this app might make it easier to stay on track with your treatment.
This study tests a new wearable device (eGERD) that aims to reduce symptoms of GERD (heartburn and regurgitation). The trial will check if the device is safe and works well without needing medication.
This study tests a new topical treatment for people with chronic heartburn and acid regurgitation who don't have erosions (damage) in their esophagus. The treatment is applied directly to the affected area and may help relieve symptoms without taking daily pills.
This study tests whether a smartphone app called FORTISKAP helps people stick to their oral medications for lung conditions like interstitial lung disease and pulmonary hypertension. If you join, you'll either use the app or receive usual care, and the goal is to see if the app improves medication routines and outcomes.
A study from Stanford University to test a mobile app that helps people with GERD (reflux) ask their doctors better questions. It aims to improve communication and symptom management.
Hear when a new GERD (Gastroesophageal Reflux Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.